Clinical Trial Update: Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports early-phase results from a study of nivolumab and ipilimumab with radiation therapy in stage III-IVB head and neck cancers, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Laryngeal Cancer
• Lip Cancer
• Oral Cavity Cancer
• Pharyngeal Cancer

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Larynx, Lip, Oral Cavity and Pharynx | EARLY_Phase 1 | Status: COMPLETED